Danli Wang

Title: Innovations of Danli Wang in Chondroitin Sulfate Oligosaccharides

Introduction

Danli Wang is an accomplished inventor based in Hangzhou, China. He has made significant contributions to the field of biochemistry, particularly in the development of fucosylated chondroitin sulfate oligosaccharides. His innovative work has the potential to impact therapeutic applications, especially in anticoagulation treatments.

Latest Patents

Danli Wang holds a patent for a "Mixture of fucosylated chondroitin sulfate oligosaccharides and method for rapidly producing the same." This invention discloses a mixture of fucosylated chondroitin sulfate oligosaccharides with an average molecular weight between 2700 Da and 3600 Da. Notably, 90% of the total components have a molecular weight ranging from 1800 Da to 5400 Da. The mixture exhibits very low anti-FIIa factor activity and very low anti-FXa factor activity, while demonstrating significant activity in selectively inhibiting intrinsic FXase. This invention has been proven to have significant antithrombotic activity without the associated risks of bleeding and hypotension, as demonstrated through animal experiments.

Career Highlights

Danli Wang is affiliated with Zhejiang University, where he continues to advance his research in biochemistry and pharmacology. His work is characterized by a focus on innovative methods for producing valuable biochemical compounds.

Collaborations

Danli Wang collaborates with notable colleagues, including Shiguo Chen and Junhui Li, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in their field.

Conclusion

Danli Wang's innovative contributions to the field of chondroitin sulfate oligosaccharides highlight his role as a leading inventor in biochemistry. His patented methods and compounds promise to advance therapeutic applications and improve patient outcomes.